DTC
NVS icon

Davidson Trust Company’s Novartis NVS Stock Holding History

Davidson Trust Company’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$563K Sell
3,685
-52
-1% -$7.97K 0.24% 103
2025
Q4 		$515K Sell
3,737
-673
-15% -$88.1K 0.21% 107
2025
Q3 		$566K Sell
4,410
-122
-3% -$14.9K 0.23% 99
2025
Q2 		$548K Sell
4,532
-605
-12% -$68.2K 0.25% 95
2025
Q1 		$573K Sell
5,137
-5,771
-53% -$614K 0.27% 90
2024
Q4 		$1.06M Buy
10,908
+707
+7% +$75.4K 0.55% 48
2024
Q3 		$1.17M Buy
10,201
+1,770
+21% +$201K 0.6% 43
2024
Q2 		$898K Sell
8,431
-73
-0.9% -$7.33K 0.62% 49
2024
Q1 		$823K Buy
8,504
+640
+8% +$65.6K 0.48% 50
2023
Q4 		$794K Buy
7,864
+112
+1% +$10.8K 0.51% 49
2023
Q3 		$790K Sell
7,752
-36
-0.5% -$3.65K 0.59% 43
2023
Q2 		$786K Buy
7,788
+1,735
+29% +$174K 0.57% 46
2023
Q1 		$557K Buy
6,053
+736
+14% +$64.3K 0.43% 60
2022
Q4 		$482K Buy
5,317
+81
+2% +$6.82K 0.43% 65
2022
Q3 		$398K Sell
5,236
-384
-7% -$31.8K 0.38% 69
2022
Q2 		$475K Sell
5,620
-142
-2% -$12.5K 0.42% 63
2022
Q1 		$506K Sell
5,762
-307
-5% -$26.6K 0.38% 70
2021
Q4 		$530K Sell
6,069
-284
-4% -$23.6K 0.36% 71
2021
Q3 		$520K Buy
6,353
+712
+13% +$64.1K 0.4% 69
2021
Q2 		$515K Sell
5,641
-312
-5% -$27.8K 0.4% 69
2021
Q1 		$507K Sell
5,953
-259
-4% -$23.2K 0.43% 64
2020
Q4 		$585K Sell
6,212
-202
-3% -$17.7K 0.5% 57
2020
Q3 		$556K Buy
6,414
+108
+2% +$9.36K 0.51% 58
2020
Q2 		$550K Buy
6,306
+502
+9% +$43.3K 0.53% 56
2020
Q1 		$477K Sell
5,804
-80
-1% -$7.14K 0.59% 50
2019
Q4 		$556K Buy
+5,884
New +$528K 0.56% 51

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Davidson Trust Company's NVS Position: Q1 2026 in Review

Davidson Trust Company reduced its Novartis (NVS) stake by 1.4% in Q1 2026, selling an estimated $7.97K and leaving 3,685 shares worth $563K. The position accounts for 0.24% of the portfolio, ranked #103.

Davidson Trust Company first reported a position in NVS in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.17M in Q3 2024. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Davidson Trust Company held 3,685 shares of Novartis worth $563K as of Q1 2026.
  • Davidson Trust Company sold 52 Novartis shares in Q1 2026, an estimated $7.97K.
  • Novartis made up 0.24% of Davidson Trust Company's portfolio in Q1 2026, its #103 holding.
  • Davidson Trust Company first reported a position in Novartis in Q4 2019 and has held it in 26 quarters since.
  • Davidson Trust Company's Novartis position peaked at $1.17M in Q3 2024.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Davidson Trust Company's 13F filing for Q1 2026, filed 20 Apr 2026.